[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,448
Citations 0
Correction
May 17, 2016

Error in Text

JAMA. 2016;315(19):2125. doi:10.1001/jama.2016.5631

In the Review entitled “Association Between Vaccine Refusal and Vaccine-Preventable Disease in the United States: A Review of Measles and Pertussis” published in the March 15, 2016, issue of JAMA,1 there was an error in the text. Under “Vaccine Refusal and Pertussis Outbreaks,” the article states, "The Advisory Committee on Immunization Practices currently recommends 5 DTaP doses at age 2, 4, and 6 months, at 15 to 18 months, and again at 4 to 6 years, as well as a Tdap booster in adolescence (between age 11 and 18 years) and adulthood (19 years or older)." It should state, "The Advisory Committee on Immunization Practices currently recommends 5 DTaP doses at age 2, 4, and 6 months, at 15 to 18 months, and again at 4 to 6 years, as well as a Tdap booster in adolescence (between age 11 and 12 years), or adulthood (if the adolescent dose was missed), and during every pregnancy." This article was corrected online.

References
1.
Phadke  VK, Bednarczyk  RA, Salmon  DA, Omer  SB.  Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. JAMA. 2016;315(11):1149-1158.
PubMedArticle
×